Company / Operating Income
Dexcom Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$911.8M
FY2025
5-year range
$265.8M / $911.8M
FY2021-FY2025
Trend
+52.0%
vs FY2024
Sector context
#30 of 156
Health Care
What the data says
Dexcom's operating income of $912M is higher than 81% of companies in the Health Care sector (FY2025). Operating Income has increased for 4 consecutive years, from $266M in FY2021 to $912M in FY2025.
Based on SEC 10-K filings.
$912M in FY2025 with a 5-year CAGR of +24.9%. Top quartile in the Health Care sector.
Improved from $598M to $912M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +44.9%
- 5-Year CAGR
- +24.9%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 156This company $911.8M Sector average $733.1M
▼
+24.4% above sector average
Key checks
Key Insights
- Dexcom's operating income has grown for 4 consecutive years.
- 5-year CAGR of +24.9%, indicating consistent growth.
- In FY2025, operating income increased 52.0% year-over-year.
- Ranks #30 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $911.8M | +52.0% |
| FY2024 | $600.0M | +0.4% |
| FY2023 | $597.7M | +99.6% |
| FY2022 | $299.5M | +12.7% |
| FY2021 | $265.8M | -11.3% |
| FY2020 | $299.5M | +110.5% |
| FY2019 | $142.3M | +176.4% |
| FY2018 | -$186.3M | -226.3% |
| FY2017 | -$57.1M | -165.6% |
| FY2016 | -$21.5M | +25.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026